Move in line with Quest's strategy to refocus on diagnostic informational services. HemoCue develops, produces, and sells testing systems that allow blood and urine tests to be run at the point of ...

NJBIZ, New Jersey’s leading business journal, provides 24/7 business news coverage and events honoring top business professionals.

MADISON, N.J. (AP) -- Medical laboratory operator Quest Diagnostics Inc. said Wednesday it plans to sell its HemoCue diagnostic products unit, which makes blood and urine tests. Quest has announced ...

As per its plan to sell the HemoCue diagnostics products business, Quest Diagnostics (DGX), recently completed the divesture of the same. The company announced that Radiometer Medical ApS purchased ...

Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, today announced that it has signed a definitive agreement to sell its HemoCue diagnostic products ...

Radiometer Limited, a leading provider of technologically advanced acute care testing solutions, is pleased to announce that following its recent acquisition of HemoCue, the Company will be offering ...

Following the divestment of its OralDNA Labs salivary-diagnostics business to Access Genetics in Dec 2012, leading diagnostic testing company, Quest Diagnostics (DGX), came up with the plan to sell ...

Co announces it has acquired HemoCue, a Swedish co specializing in near patient testing, also known as point-of- care testing, from the private equity firm E.Q.T II B.V. in a cash transaction valued ...